Morphometric and DNA image analysis of bronchoalveolar lavage fluid macrophages nuclei in interstitial lung diseases with lymphocytic alveolitis [Morfometrijska i DNA image analiza jezgara makrofaga u bronhoalveolarnom lavatu bolesnika sa bolestima plućnog intersticija i limfocitnim alveolitisom] by Smojver-Ježek, Silvana et al.
Coll. Antropol. 34 (2010) 1: 123–129
Original scientific paper
Morphometric and DNA Image Analysis of
Bronchoalveolar Lavage Fluid Macrophages
Nuclei in Interstitial Lung Diseases with
Lymphocytic Alveolitis
Silvana Smojver-Je`ek1, Tatjana Pero{-Golubi~i}2,4, Jasna Tekavec-Trkanjec2, Marija Alilovi}2,
Bo`ica Vrabec-Branica1, Zrinka Juro{1 and Ivica Ma`urani}3,4
1 Department of Cytology, University Hospital for Lung Diseases »Jordanovac«, Zagreb, Croatia
2 Department of Pneumology, University Hospital for Lung Diseases »Jordanovac«, Zagreb, Croatia
3 Department of Radiology, University Hospital for Lung Diseases »Jordanovac«, Zagreb, Croatia
4 University of Zagreb, School of Medicine, Zagreb, Croatia
A B S T R A C T
Lymphocytic alveolitis is a characteristic of diverse interstitial lung diseases (ILD-s), but macrophages are often more
numerous cell population in bronchoalveolar lavage fluid (BALF). Aim of this study is to analyze morphometric charac-
teristics of macrophages nuclei in BALF in patients with ILD-s and to detect possible differences allowing distinguish-
ing sarcoidosis from other lymphocytic alveolitis ILD-s. Thirty-one patient with interstitial lung disease who had lym-
phocytic alveolitis in BALF cell count (17 sarcoidosis and 14 other ILD-s) and nine controls were included in the study.
The following patients data were numbered: age, lymphocyte percentage and CD4/CD8 ratio in BALF. Investigated mor-
phometric parameters of macrophages nuclei were: area, outline, maximal radius, minimal radius, length, breadth,
form factor (FF), elongation factor (EF) and DNA image cytometry ploidy status determined with Van Velthoven method.
Predicted classifications in classification matrix (forward step-wise method in multivariate discriminant function anal-
ysis) based on macrophages nuclei length mean, minimum andmaximum, breadth SD, FFmean and lymphocyte % were
100% (9/9) correct for control group, 88.235% (15/17) correct for sarcoidosis, and 92.857% (13/14) correct for other lym-
phocytic alveolitis ILD group. In total, 92.5% (37/40) of the examinees were correctly classified in particular group upon
the observed variables.
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Introduction
Interstitial lung disease (ILD) includes a variety of
clinical disorders with different origin. For practical rea-
sons they can be divided in several groups: of known cause
(hypersensitivity pneumonitis), idiopathic interstitial
pneumonias, granulomatous diseases (sarcoidosis) and
rare diseases (alveolar proteinosis)1. In the differential di-
agnosis of the interstitial pulmonary disorders, sarcoi-
dosis, collagen vascular diseases, idiopathic pulmonary fi-
brosis (IPF) and bronchiolitis obliterans organising pnu-
monitis (BOOP) are the most common and responsible for
about two thirds of all cases2.
Bronchoalveolar lavage (BAL) is important diagnostic
procedure for the cell profile analysis. Lymphocyte in-
crease in differential lung lavage cell count is helpful in
differential diagnosis of ILD-s. It is most pronounced in
sarcoidosis, hypersensitivity and drug-induced pneumo-
nitis, and less intensive in IPF, BOOP, RB-ILD/DIP (re-
spiratory bronchiolitis associated interstitial lung dis-
ease) and collagen vascular diseases. CD4 /CD8 ratio in
broncholaveolar lavage fluid (BALF) is helpful in distinc-
tion of active sarcoidosis and hypersensitivity pneumo-
nits1. However most find its sensitivity and specificity to
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be inadequate for the diagnosis3. In about 4–10% of cases,
sarcoidosis presents with a CD8 lymphocytic alveolitis
and a low CD4/CD8 ratio4.
Macrophages represent the largest cell population ob-
tained by BAL from the lungs of patients with the most
ILD-a. In sarcoidosis macrophages are antigen present-
ing cells responsible for granuloma formation, but also
secrete TNFa, IL-12, IL-15, IL-8 and different growth
factors5. Their absolute number is often increased in hy-
persensitivity pneumonitis and macrophages activation
is demonstrated by the significant expression of activa-
tion markers including CD54, selectins, and costimu-
latory molecules. Recent data involve macrophages as a
cell source of chemokines that drive T-cell recruitment6.
Macrophages in sarcoidosis are larger than macrophages
in healthy controls and posses different ultrastructural
characteristics7. They are more uniform in appearance
than in hypersensitivity pneumonitis and lack foamy
characteristics8. Recently, three types of macrophages in
sarcoidosis have been recognized ultrastructurally, 70%
among them with signs of increased activity and cytokine
release9. Epithelioid cells are rare in BAL fluid and they
are a sign of disease activity. There are few morpho-
metric and DNA cytometric studies of epithelioid cells
nuclei in histological sections of sarcoid and tuberculoid
granulomas. Epithelioid cells in sarcoidosis were more el-
liptic with smaller outline, area and diameter than epi-
thelioid cells in tuberculosis10. Some authors find that
most epithelioid cells in sarcoid granuloma of lymph
nodes had aneuploid or hypodiploid DNA content11,12.
Aim of this study is to analyze morphometric and
DNA cytometric characteristics of macrophages nuclei in
BAL fluid in patients with ILD-s and controls, as well as
to detect possible differences allowing differential diag-
nosis between sarcoidosis and other lymphocytic alveo-
litis ILD-s.
Materials and Methods
BAL fluid (BALF) was obtained during diagnostic
flexible bronchoscopy. Thirty-one patients with intersti-
tial lung disease had lymphocytic alveolitis in BAL fluid
cell count (more than 15% of lymphocytes). Among them,
17 had sarcoidosis and in 14 other lymphocytic alveolitis
ILD-s were confirmed with standard diagnostic proce-
dures. Among patients with other lymphocytic alveolitis
ILD-s, clinical diagnosis was hypersensitivity pneumoni-
tis in 5 patients, 5 patients had diffuse connective tissue
diseases, in 2 patients diagnosis was IPF and BOOP in
remaining 2 patients. BAL fluid count was normal and
interstitial lung disease was not proven with other diag-
nostic procedures in 9 individuals, so they were consid-
ered controls.
Morphometric and DNA image analysis were per-
formed on macrophages nuclei in cytological specimens
of BAL fluid. Cytocentrifugation was done with the
Shandon Cytospin 4 (Shandon Scientific Ltd, Astmoor,
U.K.), speed 1000 rpm, time: 5 min and acceleration rate:
low. Number of drops per preparation was adjusted ac-
cording to the total cell count in order to obtain mono-
layer preparations. The preparations were air-dried and
subsequently stained according to the May-Grünwald-
-Giemsa (MGG) for cell differentials. Archived slides
were then restained with Feulgen method for morpho-
metric and DNA image analysis of macrophages nuclei13.
Random sampling was performed by systemic measure-
ment of cells under microscope. Cells selection started at
point inside a region with cellular material evenly dis-
tributed, proceeded cell by cell in one field, and contin-
ued to the next fields14. Light microscopic analysis under
oil immersion (x100) was applied and analysis was con-
ducted in one focal nuclear plane. In each case 100 or
more nuclei were analyzed, and processed with an image
analyzer using SFORM software for digital image analy-
sis (VAMSTEC, Zagreb). Objects contours were marked
with special tools, interactive, by mouse selection (Figure
1). Investigated morphometric parameters of macropha-
ges nuclei were simple object parameters as area, outline,
maximal radius, minimal radius, length, breadth and
complex parameters as form or regularity factor (FF)
and elongation factor (EF). Form factor (4 x area/out-
line2) describes irregularities compared with a circle,
while elongation factor is length to breadth ratio15. DNA
image cytometric analysis of ploidy status was performed
simultaneously as other morphometric measurements.
Nuclei of neutrophilic granulocytes were used for inter-
nal controls on the same slide as investigated macropha-
ges. DNA content was measured indirectly after quanti-
tative DNA staining with Feulgen. Nuclear IOD (inte-
grated optical density) represents cytometric equivalent
of DNA content, rescaling of the IOD values by compari-
son with IOD values of cells with known DNA content
was necessary for quantification of nuclear DNA content
of measured cell16. DNA image cytometry ploidy status
was determined with Van Velthoven method. This me-
thod includes near-diploid hyperdiploid and triploid his-
togram types as aneuploid types. It is superior in describ-
ing changes in DNA content of non-malignant cells with
high proliferative activity. DNA index (DI) has been cal-
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Fig. 1. Marked contours of investigated and control nuclei in
morphometric analysis procedure. Feulgen staining, original
magnification x1000.
culated as ratio between modal value of the investigated
cell peak divided by the modal value of the diploid refer-
ence cell peak. Dyploid histograms had a DI value >0.90
<1.15, hyperdiploid >1.16<1.39, triploid >1.40<1.60,
hypertiploid >1.61<1.89 and tetraploid >1.90<2.2017.
Statistical Analysis
Statistical analysis was performed in Statistica for
Windows version 6.0 (StatSoft, Inc. Tulsa, OK). Mean,
median, standard deviation and minimum andmaximum
value have been calculated for all morphometric parame-
ters. Mean, standard deviation and 95% confidence inter-
val (95% CI) were used for description of variables and
variance analysis was used for comparison between the
groups. c2-test was used for comparison of variables cate-
gories distribution among groups. Variables categories
were represented as frequency (%). Classification criteria
(diagnostic threshold values) were calculated with dis-
criminant function analysis. Forward step-wise method
in multivariate discriminant function analysis was per-
formed because of sample size and complexity.
Results
In the study were included 31 patients with ILD and
lymphocytic alveolitis in BAL fluid differential cell count
in cytological samples and 9 controls with normal differ-
ential cell count. Sarcoidosis was final diagnosis in 17 pa-
tients and various ILD entities were diagnosed in 14 pa-
tients. The following patients data were included in the
study: age, lymphocyte percentage and CD4/CD8 ratio in
BAL fluid. Investigated parameters of macrophages nu-
clei were morphometric parameters: area, outline, maxi-
mal radius, minimal radius, length, breadth, form factor
(FF), elongation factor (EF) and DNA image cytometry
ploidy status determined with Van Velthoven method.
Age range for controls was 32–77 years, (X±SD 54.67±
15.17), in sarcoidosis patients group range was 23–54
years, (X±SD 39.18±9.34) and for other lymphocytic alve-
olitis ILD group range was 27–82 years, (X±SD 57.21±
17.71). There were statistical significant differences in
age means and SD among groups (p<0.05). Lymphocyte
percentage range was 5.96–17.15, (X±SD 11.56±7.27) for
control group, in sarcoidosis patients 26.67–41.86 (X±SD
34.26±14.78) and for other lymphocytic alveolitis ILD
group range was 35.15–56.57 (X±SD 45.86±18.55), with
statistical significant differences among groups (p<
0.05). In control group CD4/CD8 ratio range was 0.8–2.5
(X±SD 1.69±0.49), in sarcoidosis group 0.7–16.1, X±SD
6.85±4.37 and for other lymphocytic alveolitis ILD group
range was 0.3–6.8 with X±SD 0.29±26.48. CD4/CD8 ratio
showed no significant differences between groups (p>
0.05). DNA image cytometry results obtained with Van
Velthoven method showed predominant hyperdiplod
DNA content (DI>1.16<1.39), 6/9 in control group, pre-
dominant triploid DNA content (DI>1.40<1.60), 9/14 in
other lymphocytic alveolitis ILD group and 10/17 in
sarcoidosis group; with statistical significant differences
among controls and investigated groups (c2-test, p<
0.05). Mean, standard deviation (SD) and 95% confidence
interval (95% CI) of investigated morphometric parame-
ters for the groups (controls, sarcoidosis and other lym-
phocytic alveolitis ILD) have been summarized in Table
1.
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TABLE 1
MEAN VALUE, STANDARD DEVIATION AND 95% CONFIDENCE INTERVAL OF INVESTIGATED MORPHOMETRIC PARAMETERS FOR
THE GROUPS
Morphometric parameter Controls (n=9)
ILD patients (n=31)
Sarcoidosis (n=17) Other LA-ILD (n=14)
Area (mm2)
85.696±9.699
78.241–93.151
96.777±6.358
93.508–100.047
102.577±8.298
97.786–107.368
Outline (mm)
37.801±1.812
36.408–39.194
40.901±1.844
39.953–41.849
41.070±2.333
39.723–42.417
Minimal radius (mm)
4.198±0.285
3.978–4.417
4.105±0.251
3.977–4.235
4.205±0.294
4.035–4.375
Maximal radius (mm)
6.202±0.312
5.963–6.442
6.957±0.374
6.764–7.149
7.177±0.550
6.860–7.495
Length (mm)
12.030±0.633
11.543–12.517
13.441±0.681
13.090–13.791
13.889±1.047
13.285–14.494
Breadth (mm)
9.255±0.565
8.821–9.690
9.496±0.347
9.318–9.674
9.706±0.354
9.501–9.910
Elongation factor (EF)
1.315±0.047
1.279–1.351
1.439±0.085
1.396–1.483
1.458±0.122
1.388–1.529
Form factor (FF)
0.752±0.027
0.731–0.772
0.737±0.047
0.713–0.760
0.771±0.033
0.752–0.791
ILD – interstitial lung disease, LA-ILD – lymphocytic alveolitis interstitial lung disease
Statistical descriptions of values (mean, median, SD,
minimum, maximum) that were significantly different
between controls, sarcoidosis and other lymphocytic
alveolitis ILD groups for each morphometric parameter
have been shown in Table 2. Parameters: area, outline,
maximal radius and length were statistically significant
(p<0.05) among groups according to statistical descrip-
tions. Additionally, all statistical descriptions of nuclei
areas, outlines, maximal radius, length, elongation factor
and form factor median and standard deviation were the
lowest in control group compared with ILD-s groups. All
mean values and medians of investigated morphometric
parameters were highest in other lymphocytic alveolitis
ILD group, but there were differences in the highest val-
ues in SD, minimum and maximum of all investigated
parameters, most of them were in sarcoidosis group, ex-
cept the least value of minimal radius minimum and
form factor (FF) minimum and maximum values in con-
trol group (Table 3). Variables obtained with discrimi-
nant forward step-wise analysis were used as classifica-
tion functions for investigated groups, including mor-
phometric parameters of macrophages nuclei, as well as
percent of lymphocytes in BALF cell count. Morpho-
metric parameters of macrophages nuclei used for classi-
fication matrix were length mean, minimum and maxi-
mum, breadth standard deviation and form factor (FF)
mean. Their characteristics were summarized in Table 4.
The classification matrix shows the number of cases that
were correctly classified on the diagonal of the matrix
and those that were misclassified. Predicted classifica-
tions in classification matrix based on macrophages
nuclei length mean, minimum and maximum, breadth
SD, FF mean and lymphocyte % were 100% (9/9) correct
for control group, 88.235% (15/17) correct for sarcoidosis,
as well as 92.857% (13/14) correct for other lymphocytic
alveolitis ILD group (Table 5). In total, 92.5% (37/40) of
the examinees were correctly classified in particular groups
with observed variables.
Discussion
The present study demonstrates statistical significant
differences in morphometric characteristics of macro-
phages nuclei in controls, sarcoidosis and other ILD
groups with lymphocytic alveolitis.
Classification matrix based on macrophages nuclei
length mean, minimum and maximum, breadth standard
deviation (SD), form factor (FF) mean and percentage of
lymphocytes was 92.5% correct for all groups, 100% cor-
rect for control group, 88.235% correct for sarcoidosis,
and 92.857% correct for other lymphocytic alveolitis ILD
group.
Bronchoalveolar lavage in the interstitial lung dis-
eases is considered helpful in sarcoidois, hypersensitivity
pneumonitis, alveolar proteinosis, detection of dust par-
ticles and asbestos bodies, or identification of malignant
cells8,18. Macrophages play an important role in the de-
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TABLE 2
COMPARISON BETWEEN INVESTIGATED PARAMETERS IN GROUPS (VARIANCE ANALYSIS)
Parameters Ly% Age
EF
(Elonga-
tion fac-
tor)
FF
(Form
factor)
Area Outline
Min
radius
Max
radius
Length Breadth
Statistical
descriptions
with p-values <0.05
Mean SD Mean SD
Mean
SD
Max
SD
Min
Max
All All
SD
Min
Max
All All
Mean
SD
Min
Max
Mn – mean value, SD – standard deviation, Max – maximum value, Min – minimum value, All – mean, median, standard deviation,
maximum and minimum values
TABLE 3
HIGHEST MEAN VALUES FOR EVERY MORPHOMETRIC PARAMETER IN GROUPS ACCORDING TO STATISTICAL DESCRIPTIONS
Area Outline
Minimum
radius
Maximum
radius
Lenghth Breadth EF FF
Controls Min
Min
Max
Sarcoidosis
SD
Max
SD
Max
SD
Max
SD
Max
SD
max
SD
Max
SD
Max
SD
Other LA- ILD
Mn
Md Min
Mn
Md Min
Mn
Md
Mn
Md
Min
Mn
Md Min
Mn
Md
Min
Mn
Md Min
Mn
Md
Mn – mean, Md – median, SD – standard deviation, Max – maximum value, Min – minimum value, EF – elongation factor, FF – form
factor, LA-ILD – lymphocytic alveolitis interstitial lung disease
velopment of ILD-s. They are activated and produce
cytokines. Sarcoidosis has been characterized by the pro-
duction of TNFa, IL-12, IL-15, and IL-8, in hypersensi-
tivity pneumonitis macrophages produce TNFa, IL-1
and IL-8. Regulatory cytokines, such as IL-10, are also
secreted and may play a regulatory role, soluble TNF re-
ceptors are inhibitors of TNF and can block TNF bio-
activity1,19. Differences in macrophages size and foamy
appearance of cytoplasms are visible in light and electron
microscope7–9. In the study of Burkhardt et al.9, 70% of
macrophages nuclei in sarcoidosis were indented. Cellu-
lar BALF profile of a drug-induced hypersensitivity reac-
tion appeared to be similar to the hypersensitivity pneu-
monitis profile, with lymphocyte increase and foamy
cytoplasms20. Studies of Drent and colleagues proposed
the computer model and showed that predominant cells
obtained by BALF may differentiate between three com-
mon interstitial lung diseases: sarcoidosis, hypersensitiv-
ity pneumonitis and idiopathic pulmonary fibrosis, that
cover about 80–90% of ILD20,21. Updated version was
helpful to distinguish disorders of a bacterial infectious
origin and three mentioned ILD20. The data needed for
the model were BAL volume recover, the total and differ-
ential cell count, patients gender, age and smoking sta-
tus20–22. Our study for the first time proposes a model
based on morphometric parameters of macrophages nu-
clei in cytological smears of BALF in differential diagno-
sis of sarcoidosis and other lymphocytic alveolitis ILD
groups. Furthermore, morphometric analysis in our stu-
dy revealed statistical significant differences with vari-
ance analysis among controls, sarcoidosis and other lym-
phocytic alveolitis ILD groups in nuclei area, outline,
maximal radius and length. Highest maximum values
and standard deviations in all morphometric parameters
except form factor have been found in sarcoidosis. Form
factor is complex shape factor, it is 1 in perfect round
shapes, less than 1 as shape is more elliptic or irregular.
Increase in standard deviation (SD) of nuclei area is the
exact criterion of variations in nuclei size15. Form factor
in our study had highest standard deviation in macro-
phages nuclei in sarcoidosis that reflects variability in
nuclei shape. This finding is opposite to relatively uni-
form appearance of macrophages in sarcoidosis usually
described in light microscope, referred to more visible cy-
toplasmic appearance7,8. In the study of Tosi and col-
leagues differences in shape of nuclear profiles of epithe-
lioid cell in sarcoidosis and tuberculosis were best de-
monstrated by form factor10.
Elongation factor as length to breadth ratio could sort
out elongated, slender nuclei, as those in epithelioid cells.
Elongation factor showed highest maximum values and
standard deviations in sarcoidosis group, but highest
means and medians of elongation and form factors were
in non-sarcoidosis group. Combination of standard devia-
tions, means and medians of elongation and form factors
of macrophages nuclei could reflect finding of epithelioid
like cells in sarcoidosis. More clinical data and morpho-
metric parameters combinations are needed to confirm
these observations.
Apoptosis impairment, probably reduction, has been
involved in pathogenesis of sarcoidosis and other ILD-s23–25.
Cells undergoing apoptosis are smaller with irregular
contours26,27. Detection of these cells on morphological
basis is possible, but BALF cells could posses degenera-
tive changes similar to apoptotic. Observed morphome-
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TABLE 4
MEAN VALUE AND STANDARD DEVIATION OF DISCRIMINANT PARAMETERS USED AS CLASSIFICATION FUNCTIONS FOR GROUPS
Parameters Controls (n=9)
ILD patients (n=31)
Sarcoidosis (n=17) Other LA-ILD (n=14)
lymphocytes (%) 11.56±7.27 34.26±14.78 45.86±18.55
Length Mean (mm) 12.030±0.633 13.441±0.681 13.889±1.047
Length Max (mm) 15.713±1.148 20.896±1.492 20.510±2.177
Length Min (mm) 8.866±0.593 9.607±0.620 10.116±0.847
Breadth SD (mm) 1.013±0.102 1.271±0.163 1.117±0.065
Form factor (FF) Mean 0.752±0.027 0.737±0.047 0.771±0,033
SD – standard deviation, ILD – interstitial lung disease, LA-ILD – lymphocytic alveolitis interstitial lung disease
TABLE 5
CLASSIFICATION MATRIX FOR GROUPS (MULTIVARIATE DISCIMINANT FUNCTION ANALYSIS, FORWARD STEP-WISE METHOD)
Percent Correct Controls Sarcoidosis Other LA-ILD
Controls 100.000 9 0 0
Sarcoidosis 88.235 0 15 2
Other LA-ILD 92.857 0 1 13
Total 92.500 9 16 15
Rows: observed classifications, columns: predicted classifications; LA-ILD – lymphocytic alveolitis interstitial lung disease
tric differences in macrophages nuclei among groups in
our study could be, partially, a result of pathogenesis dif-
ferences.
Lymphocyte increase in differential lung lavage cell
count is most pronounced in sarcoidosis, hypersensitivity
and drug-induced pneumonitis, and less intensive in IPF,
BOOP, RB-ILD/DIP and collagen vascular diseases28.
Lymphocyte percentage range in our study showed sta-
tistical significant differences among sarcoidosis and
other lymphocytic alveolitis ILD-s group, more pronoun-
ced in later, probably due to hypersensitivity pneumoni-
tis group. CD4/CD8 ratio is helpful in diagnosis of sarcoi-
dosis and hypersensitivity pneumonitis, but not chara-
cteristic3–5. We found similar results, with no significant
differences. BAL cellular analysis is also dependent on
the quality of the obtained lavage specimen. BAL cellu-
larity is influenced by the technical preparation of BAL
recovery. When using cytocentrifugation, counting in a
circular pattern around the center area is required, as
cells, especially lymphocytes might not equally distribute
over the cytocentrifuged spot4. This factor can be elimi-
nated by using a standardized protocol as in our study.
DNA cytometry has been reserved for malignant
changes, because malignant cells and cells with rapid di-
vision have shorter cell cycle than normal cells. Normal
cells with high proliferative activity as in gastric mucosa
and breast epithelia have nuclear DNA content amounts
distributions in diploid-tetraploid regions. Hyperplastic
processes showed a polymodal distribution of DNA con-
tent values with few aneuploid values29. Burkhardt find
that 30% of macrophages nuclei in sarcoidosis had den-
sified heterochromatin as result of increased metabolic
activity9. DNA image cytometry results of macrophages
in our study analyzed with Van Velthoven method sho-
wed predominant triploid DNA content in groups with
ILD-s and predominant hyperdiplod DNA content in
control group, with statistical significant differences
among investigated groups. Macrophages in controls had
predominant aneuploid/hyperdiploid DNA content possi-
bly due to activation during transformation in BAL fluid.
This finding was typical for benign cells with high pro-
liferative activity, as previously reported for gastric mu-
cosa cells, breast epithelial cells and macrophages and
epithelioid granuloma cells in sarcoidosis9,11,12,29. Macro-
phages in other lymphocytic alveolitis ILD-s have been
also characterized with proliferative activity and aneu-
ploid/triploid DNA content can be expected.
Our study showed possible differentiation of healthy
controls and patients with lymphocytic alveolitis ILD-s,
and furthermore classification of ILD-s to sarcoidosis
and other lymphocytic alveolitis ILD groups on the basis
of macrophages nuclei morphology in BALF. Morpho-
metric nuclear parameters determined by forward step-
-wise method in multivariate discriminant function anal-
ysis were length (mean, minimum and maximum value),
breadth – standard deviation (SD) and form factor (FF) –
mean value. These parameters together with percentage
of lymphocytesl in BALF cell count allowed 92.5% overall
correct classification of examinees, 100% for controls,
88.235% for sarcoidosis, and 92.857% correct classifica-
tion for other lymphocytic alveolitis ILD group.
Conflict of Interest
No financial or other potential conflict of interest ex-
ist among the authors.
Acknowledgements
The authors gratefully acknowledge Ivan~ica Peha-
rec, head cytotechnologist, for technical support.
R E F E R E N C E S
1. TRAVISWD, KING TE, BATEMANE, Am J Respir Crit Care Med,
165 (2002) 227. — 2. PERO[-GOLUBI^I] T, SHRAMA OP, Definition,
Classification, and Clinical Features. In: PERO[-GOLUBI^I] T, SHRA-
MA OP (Eds) Clinical Atlas of Interstitial Lung Disease (SV, London,
2006). — 3. JUDSONMA, Am J Med Sci, 335 (2008) 26. — 4. REICHEN-
BERGER F, KLEIBER B, BASCHIERA B, Respir Med, 101 (2007) 2025.
— 5. HUNNINGHAKE GW, COSTABEL U, ANDO M, BAUGHMAN R,
CORDIER JF, DU BOIS R, EKLUND A, LINCH J, RIZZATO G, ROSE C,
SELROOS O, SHARMA OP, Saroidosis Vasc Diffuse Lung Dis, 16 (1999)
149. — 6. AGOSTINI C, TRENTIN L, FACCO M, SEMENZATO G, Curr
Opin Pulm Med, 10 (2004) 378. — 7. DANEL C, DEWAR A, CORRIN B,
TURNER-WARWICK M. CHRETIEN J, Am J Pathol, 112 (1983) 7. — 8.
COSTABEL U, GUZMAN J, Curr Opin Pulm Med, 7 (2001) 255. — 9.
BURKHARDT O, LODE H, WELTE T, MERKER HJ, Micron, 38 (2007)
572. — 10. TOSI P, MIRACCO C, LUZI P, CINTORINO M, KRAFT R,
COTTIER H, Analyt Quant Cytol Histol, 8 (1986) 233. — 11. OKABE T,
SUZUKI A, ISHIKAWA H, WATANABE I, TAKAKU F, Am Rev Respir
Dis, 134 (1986) 300. — 12. ORNVOLD K, CARSTENSTEN H, CHRIS-
TIENSEN I, KARSEN JK, CHRISTIENSEN U, J Clin Pathol, 42 (1989)
1225. — 13. BÖCKING A, STRIEPECKE E, AUER H, FUZESI L, Static
DNA cytometry: biological background, technique and diagnostic inter-
pretation. In: WIED GL, BARTELS PH, ROSENTHAL DL, SCHENCK
U (Eds) Compendium on the computerized cytology and histology labora-
tory (Tutorials of Citology, Chicago, 1994). — 14. HAROSKE G, GIROUD
F, REITH A, BÖCKING A, Anal Cell Pathol, 17 (1998) 189. — 15. VAN
DIEST PJ, BAAK JPA, Morphometry. In: BIBBO M (Ed) Comprehensive
cytopathology (WBSC, Philadelphia, 1991). — 16. HAROSKE G, BAAK
JPA, DANIELSEN H, GIROUD F, GSCHWENDTNER A, OBERHOLZER
M, REITH A, SPIELER P, BÖCKING A, Anal Cell Pathol, 23 (2001) 89. —
17. VAN VELTHOVEN R, PETEIN M, OOSTERLINCK WJ, ZANDONA
C, ZLOTTA A, VAN DER MEIJDEN APM, PASTEELS JL, ROELS H,
SCHULMAN C, KISS R, Hum Pathol, 26 (1995) 3. — 18. ROTTOLI P,
BARGAGLI E, Curr Opin Pulm Med, 9 (2003) 418. — 19. BOURKE SJ,
DALPHIN JC, BOYD G, McSHARRY C, BALDWIN CI, CALVERT JE,
Eur Respir J, 18 (2001) 81. — 20. DRENTM, JACOBS JA, COBBENNAM,
COSTABEL U, WOUTERS EFM, MULDER PGH, Respir Med, 95 (2001)
781. — 21. DRENT M, NIEROP VAN MAMF, GERRITSEN FA, WOUN-
TERS EFM, MULDER PGH, Am J Respir Crit Care Med, 153 (1996) 736.
— 22. DRENTM, MULDER PGH, WAGENAAR SS, HOOGSTEDEN HC,
VELZEN-BLAD VAN H, BOSCH VAN DEN JMM, Eur Respir J, 6 (1993)
803. — 23. CREE IA, NURBHAI S, MILNE G, SWANSON BECK J, J Clin
Pathol, 40 (1987) 1314. — 24. RUHTERFORD RM, KEHREN J, STAED-
TLER F, CHIBOUT SD, EGAN JJG, TAMM M, GILMARTIN JJ, BRUT-
SCHE MH, Swiss Med Wkly, 131 (2001) 459. — 25. MERMIGKIS C, PO-
LYCHRONOPOULOS V, MERMIGKIS D, TSAKANIKA K, HERETIS M,
KARAGIANIDIS N, BOUROS D, Respiration, 73 (2006) 221. — 26. BLAN-
COA,MONTERDE JG,MENDEZ A, ARTACHO-PERULAE, Cells Tissues
Organs, 169 (2001) 73. — 27. HÄCKER G, Cell Tissue Res, 301 (2000) 5.
— 28. WELKER L, JÖRRES RA, COSTABEL U, MAGNUSSEN H, Eur
Respir J, 24 (2004) 1000. — 29. ENCHEV V, Analyt Quant Cytol Histol,
20 (1998) 288.
S. Smojver-Je`ek et al.: Morphometry of Macrophages Nuclei in Lung Diseases, Coll. Antropol. 34 (2010) 1: 123–129
128
S. Smojver-Je`ek
Department of Cytology, University Hospital for Lung Diseases »Jordanovac«, Jordanovac 104, 10 000 Zagreb, Croatia
e-mail: ssmojver@pbf.hr
MORFOMETRIJSKA I DNA IMAGE ANALIZA JEZGARA MAKROFAGA U BRONHOALVEOLARNOM
LAVATU BOLESNIKA SA BOLESTIMA PLU]NOG INTERSTICIJA I LIMFOCITNIM ALVEOLITISOM
S A @ E T A K
Makrofagi su u ve}ine bolesti plu}nog intersticija, kao i u limfocitnom alveolitisu, najbrojnija stani~na populacija u
bronhoalveolarnom lavatu. Cilj rada bio je uz morfometrijsku analizu jezgara makrofaga u bronhoalveolarnom lavatu
bolesnika sa bolestima plu}nog intersticija procijeniti mogu}nosti razlikovanja sarkoidoze od drugih bolesti intersticija
koje se prezentiraju limfocitnim alveolitisom. U ispitivanje je uklju~en trideset i jedan bolesnik sa bolestima plu}nog
intersticija i limfocitnim alveolitisom u bronhoalveolarnim lavatu (17 bolesnika sa sarkoidozom i 14 bolesnika sa dru-
gim bolestima) i 9 kontrolnih ispitanika. Bilje`eni su dob bolesnika, postotak limfocita i omjer CD4 i CD8 T limfocita u
bronhoalveolarnom lavatu. Analizirani su morfometrijski parametari jezgara makrofaga: povr{ina, opseg, najve}i polu-
mjer, najmanji polumjer, duljina, {irina, faktor oblika (FF), faktor izdu`enosti (EF), te DNA indeks odre|en metodom
po Van Velthovenu. Multivariatnom diskriminativnom analizom uz kori{tenje stupnjevitog eliminiranja identificirane
su varijable: prosjek, minimalne i maksimalne vijednosti duljine, SD {irine, prosjek faktora oblika (FF) i prosjek postot-
ka limfocita. Ove varijble omogu}uju razlikovanje pojedinih skupina: potpuno razlikovanje (9/9) kontrolne skupine,
88,235% (15/17) razlikovanje skupine bolesnika sa sarkoidozom i 92,857% (13/14) skupine sa drugim bolestima plu}nog
intersticija i limfocitnim alveolitisom. Identificirane varijable omogu}uju to~no klasificiranje 92,5% (37/40) ispitanika.
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